Bosentan Hydrate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Bosentan Hydrate Product Information
Bosentan Hydrate is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Bosentan. The product is supplied by Clearsynth under CAT No. CS-O-00970.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Bosentan Hydrate
CAS No.
157212-55-0
CAT No.
CS-O-00970
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C27H31N5O7S
Molecular Weight
569.63
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Bosentan Hydrate is supplied with detailed characterization data compliant with regulatory guideline. Bosentan Hydrate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Bosentan.
Overview
"Bosentan is a sulfonamide-derived, competitive and specific endothelin receptor antagonist with a slightly higher affinity for the endothelin A receptor than endothelin B receptor. Bosentan blocks the action of endothelin 1, an extremely potent endogenous"
Synonyms
Bosentan Hydrate
Application Notes
"Bosentan is a sulfonamide-derived, competitive and specific endothelin receptor antagonist with a slightly higher affinity for the endothelin A receptor than endothelin B receptor. Bosentan blocks the action of endothelin 1, an extremely potent endogenous"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.